GABBR1 and attention deficit-hyperactivity disorder: Previous research has shown that ADHD may be related to insufficient responses of the GABAergic system in frontostriatal circuitry [91]; thus, we propose that inhibition of receptor genes such as GABA-B-R1 may be a potential mechanism for the treatment of ADHD using MPH.